Month: January 2017

Momenta Pharmaceuticals, Inc. MNTA announced that it has entered into an exclusive research collaboration and worldwide license agreement with CSL Limited. […]

Advanced Micro Devices AMD recently provided preliminary details about its most anticipated upcoming Graphic Processor Unit (GPU) architecture, Vega. The new GPU card will use second-generation High Bandwidth Memory (HBM 2), which means faster transferring of terabytes of data and much greater memory capacity. Per AMD “ Vega architecture is optimized for streaming very large datasets and can work with a variety of memory types with up to 512TB of virtual address space .” The capability arises from two new HBM 2-related features, High Bandwidth Cache and High Bandwidth Cache Controller […]

Modernity has given us many wonderful things. In fact, some things that were pretty much sci-fi in my growing-up years have transformed into “technology” today. […]

Visa Inc. V has finally reached an agreement with Wal-Mart Stores, Inc. WMT , which would allow acceptance of Visa credit cards as a form of payment in all Canadian Wal-Mart stores […]

We issued an updated research report on Vale S.A. VALE on Jan 6, 2017. This Zacks Rank #1 (Strong Buy) stock looks bullish at the moment. […]

After American International Group, Inc. AIG completed the sale of its mortgage insurance unit United Guaranty Residential Insurance Company (“UGRIC”) to Arch Capital Group Ltd ACGL , the Moody’s Investor Service jumped into action. The rating agency, which is a wing of Moody’s Corp MCO , confirmed the insurance financial strength (IFS) rating of “Baa1” on UGRIC […]

Roche Holding AG RHHBY announced today that the FDA has approved a label expansion of ophthalmology drug Lucentis. Notably, Roche has underperformed the Zacks classified Large Cap Pharmaceuticals industry in the last twelve months. In fact, the stock has lost 10.9% in the last twelve months, compared with a drop of 1.0% for the industry The FDA approved Lucentis 0.5 mg for the treatment of patients with myopic choroidal neovascularization (mCNV) […]

The Dow continued to gain over the first week of the New Year as stocks returned to their winning ways. After remaining closed on Monday for a holiday, the index increased on Tuesday, the first trading day of 2017 as investors strived to make up for losses suffered during the last few sessions of profit booking. […]

Apple Inc. AAPL recently announced that its App Store generated record sales of more than $20 billion for developers in 2016, up almost 40% from 2015. According to The Wall Street Journal , the revenue figure was nearly $28.5 billion and the company collected almost $8.5 billion from these sales compared with roughly $6 million in 2015 […]

The U.S. Energy Department's inventory release showed that crude stockpiles fell sharply last week, dragging down the overall surplus. But strategic supplies at the Cushing, OK storage experienced a big build […]

Most of the stocks ended 2016 in green, thanks to the post-election rally. While the year began on a sour note given several concerns plaguing the markets, the rally in the last two months mitigated losses to a great extent. The small-cap companies, whose financial performance is primarily tied with the domestic economy, were one of the biggest winners in 2016 […]

The Manitowoc Company, Inc. MTW has disappointed investors lately. The leading global manufacturer of cranes and lift solutions, continues to grapple with lower demand for its cranes due to the current world-wide economic environment. […]

While some investors may abhor the idea of putting in money into "sin stocks," this sector is known for providing stable income despite economic downturns. The products or services in this space are relatively inelastic and the businesses are almost recession-immune, while less competition ensures higher margins and solid profits. And why not […]